JDRF - Juvenile Diabetes Research Foundation

Prime Minister Kevin Rudd yesterday committed to match a $500,000 funding contribution made by President of the Juvenile Diabetes Research Foundation (JDRF) in Australia, Dr Susan Alberti AO. He also committed to additional matching government funding for JDRF to a total of $5 million into the future.

One hundred JDRF Youth Ambassadors aged 3 to 32, all with type 1 diabetes, converged on Parliament House to personally ask for government funding for type 1 diabetes research and a Clinical Trials Network (CTN).

Read more...

A South Australian woman has become the first person to receive an islet transplant at Queen Elizabeth Hospital in Adelaide.

Margaret Harrigan, a teacher from Adelaide, is producing her own insulin for the first time since being diagnosed with type 1 diabetes 36 years ago after receiving an islet transplant in January.

Margaret had spent years living with hypoglycemia unawareness – severe and uncontrollable blood glucose fluctuations that made day-to-day living almost impossible. Four weeks after the transplant, Margaret has almost halved her insulin requirement and is free of dangerous low blood sugar attacks.

Read more...

Are you under 30 years of age and have a relative with type 1 diabetes? Perhaps you have type 1 diabetes yourself and have family members that would like to make a contribution towards a cure.

The Type 1 Diabetes Prevention Trial is an exciting study being run across Australia and New Zealand by the Diabetes Vaccine Development Centre (DVDC). Investigators are using an insulin nasal spray vaccine to try to protect people who are genetically at risk of type 1 diabetes.

Read more...

“Stem cell tourism” is a term that has recently emerged to describe the increasing number of people heading overseas for medical stem cell treatments that are not approved or available in Australia.

In Australia, and many other countries around the world, stem cell therapy is only approved to treat blood disorders such as leukemia. Whilst research is moving rapidly and showing great promise, the use of any type of stem cell as a therapy for diseases like type 1 diabetes is still firmly classed as experimental. This doesn’t mean these therapies won’t work, just that scientists and clinicians have deemed there isn’t enough data available to demonstrate patient safety as well as a long term benefit.

Read more...

One hundred Juvenile Diabetes Research Foundation Youth Ambassadors aged 3 to 40, all with type 1 diabetes, will converge on Canberra to plead for continued government funding for type 1 diabetes research on 18 March.

Supported by a crowd of family members, total numbers at Kids in the House will hit 300. They are visiting Canberra as representatives of the 140,000 children and adults in Australia with type 1 diabetes, and the tens of thousands more who care for them.

Read more...